New Market Study Published: Brazil Pharmaceuticals & Healthcare Report Q1 2013
BMI View: The Brazilian pharmaceutical market remains our favourite regional market in Latin America due to its large market size and strong domestic demand for innovative, high-tech products. The government is increasingly investing in the healthcare sector and pharmaceutical industry to reduce the financial burden of diseases, and the country's private healthcare sectors provide opportunities for foreign companies. However, the increasing drug rebate level has significantly undermined the profits recorded by generic drugmakers. The more aggressive government techonology transfer deals...
View full press release